Skip to content

MEDP

Medpace Holdings, Inc.

NASDAQ · Healthcare · Medical - Diagnostics & Research · US

$619.66
+0.19%
Ask drillr
Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open
$619.33
From 52W high
−1.67%
Volume
233688.00
Market cap
$17.30B
P/E (Fwd)
32.9x
EV/EBITDA
27.5x
P/E (TTM)
35.6x
RSI (14)
54.9
1D Return
+0.19%
YTD Return
+10.71%
SummaryUpdated Jun 1, 2026

Medpace Holdings, Inc. (NASDAQ:MEDP) is a Cincinnati-based contract research organization (CRO) founded in 1992 that provides clinical trial services to pharmaceutical, biotechnology, and medical device companies. The company went public in August 2016 and has established itself as a specialized CRO focused primarily on serving biotech clients through the complete clinical development process from Phase I through Phase IV trials across various therapeutic areas.

Similar companies

Latest newsMore news →